|
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20090113220938im_/http://oba.od.nih.gov/images/CLEAR.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090113220938im_/http://oba.od.nih.gov/images/CLEAR.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090113220938im_/http://oba.od.nih.gov/images/CLEAR.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090113220938im_/http://oba.od.nih.gov/images/CLEAR.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090113220938im_/http://oba.od.nih.gov/images/CLEAR.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090113220938im_/http://oba.od.nih.gov/images/CLEAR.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090113220938im_/http://oba.od.nih.gov/images/CLEAR.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090113220938im_/http://oba.od.nih.gov/images/CLEAR.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090113220938im_/http://oba.od.nih.gov/images/CLEAR.gif) |
|
|
|
|
Recombinant DNA News |
|
|
|
OBA Posts Frequently Asked Questions about Research Constituting a "Major Action" |
|
|
|
Under Section III-A of the NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines), experiments involving the transfer of a drug resistance trait are considered "Major Actions" if the acquisition of the trait could potentially compromise the use of the drug in question to control disease agents in humans, veterinary medicine, or agriculture. Notice of such experiments must be published in the Federal Register. In order to proceed, the experiments must be reviewed by the RAC and specifically approved by the NIH Director. If the NIH approves the experiment, the agency will specify appropriate biosafety containment. |
|
|
|
OBA frequently receives questions about this provision of the NIH Guidelines, and has thus prepared a set of answers, now available on its Web site, to respond to the most frequently asked questions (FAQs). The aim of the FAQs![](https://webarchive.library.unt.edu/eot2008/20090113220938im_/http://oba.od.nih.gov/images/CLEAR.gif) is to provide readily accessible information on the matters most commonly in need of clarification. Institutional staff and investigators may also contact OBA directly by email or telephone with any additional questions they may have. These questions may be directed to Gene Rosenthal, Ph.D., Biotechnology Program Advisor, NIH OBA, at 301-496-9838 or rosenthg@od.nih.gov. Written queries may also be sent to oba@od.nih.gov. |
|
|
|
(Posted March 21, 2008)
|
|
|
|
Archived RAC News
|
|
Top of Page |
|
|
|
|
Genetics, Health, Society News |
|
|
|
Today, the Surgeon General released a new version of "My Family Health Portrait." This internet-based tool makes it easy for consumers to record their family health history. The new version of the tool is updated for 21st century medicine. It is a standards-based electronic tool, making information easy to share and ready for use in electronic health records (EHRs) and personal health records (PHRs). The tool is also available on an "open source"-type basis, so that other organizations can download and customize it under their own brands. |
|
|
|
My Family Health Portrait |
|
|
|
(Posted January 13, 2009)
|
|
|
|
Archived SACGHS News |
|
Top of Page |
|
|
|
|
Dual Use Research News |
|
|
|
Archived NSABB News |
|
Top of Page |
|
|
|
|
Clinical Research Policy News |
|
|
|
Archived CRpac News
|
|
Top of Page |
|
|
|